Aspen Aerogels, Inc. ASPN
5.22
(0.08)
(1.51%)
as of 25 Sep
- Market cap
- $440.7M
- P/E
- 0.0×
Follow ASPN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.63 | 0.86 | 1.23 | 2.60 | |
P/FCF ratio |
213.59 | 0.00 | 7.96 | 15.29 | |
P/Operating CF |
38.14 | 14.44 | 8.29 | (32.44) | |
P/B ratio |
1.88 | 0.99 | 1.33 | 2.73 | |
Price to Tangible BV |
1.88 | 0.99 | 1.33 | 2.73 | |
EV/Sales |
1.51 | 0.68 | 0.87 | 2.30 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
10.14 | 5.61 | 3.26 | 9.48 | |
EV/FCF |
197.92 | (40.26) | 5.62 | 13.55 | |
Quick Ratio |
3.13 | 3.13 | 2.41 | 1.96 | |
Current Ratio |
3.94 | 3.90 | 2.89 | 2.52 | |
Net Debt/EBITDA |
(14.05) | 1.18 | 6.05 | 2.62 | |
Debt/Assets |
22.45% | 27.02% | 22.54% | 23.82% | |
Debt/Equity |
0.36 | 0.47 | 0.43 | 0.49 | |
Asset Turnover |
0.55 | 0.42 | 0.48 | 0.44 | |
Operating CF/Net income |
(2.37) | (0.22) | (1.44) | 0.70 | |
Capex/Depreciation |
(1.43) | (0.08) | (0.19) | (0.30) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3.42% | 6.76% | 7.19% | 6.41% | |
Selling, General and Administrative Expense of Revenue |
27.51% | 52.46% | 57.96% | 40.01% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.99% | 4.06% | 4.93% | 3.75% | |
Graham Net Nets |
0.16 | 0.30 | 0.20 | 0.09 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(53.45%) | (167.49%) | (39.77%) | (24.13%) | |
Free Cash Flow Yield |
0.47% | (1.96%) | 12.57% | 6.54% | |
Revenue per Share |
0.89 | 0.50 | 0.46 | 0.60 | |
Operating CF per Share |
0.18 | 0.20 | 0.41 | (0.20) | |
Capex per Share |
(0.11) | (0.03) | (0.02) | (0.02) | |
Free Cash Flow per Share |
0.07 | 0.17 | 0.40 | (0.22) | |
Cash per Share |
1.85 | 1.93 | 2.12 | 1.85 | |
Shareholders Equity per Share |
3.71 | 2.86 | 2.58 | 2.32 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.71 | 2.86 | 2.58 | 2.32 | |
Free Cash Flow |
5.93 | 13.67 | 32.78 | (18.00) | |
Working Capital |
208.18 | 180.03 | 166.17 | 149.85 | |
Capital Expenditures |
(9.10) | (2.46) | (1.37) | (1.80) | |
Net Current Asset Value |
93.26 | 70.89 | 56.99 | 48.02 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.12 | 0.06 | 0.04 | 0.04 | |
Net Profit Margin |
(8.67%) | (176.38%) | (62.54%) | (46.67%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
92.17 | 72.19 | 56.90 | 58.22 | |
Average Payables |
30.69 | 28.80 | 26.77 | 23.98 | |
Average Inventory |
45.23 | 42.90 | 43.90 | 40.03 | |
Average Assets |
636.99 | 650.91 | 482.73 | 459.03 | |
Average Common Equity |
406.69 | 425.11 | 264.17 | 250.62 |
Columns are period end dates